Jaguar Health, Inc. (JAGX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.479 Greetings and welcome to Jaguar Health Investor Webcast. 00:00:04.479 -- 00:00:07.805 At this time, all participants are in a listen-only mode. 00:00:07.805 -- 00:00:11.912 If anyone should require operator assistance during the conference, please press star 00:00:11.912 -- 00:00:14.516 zero on your telephone keypad. 00:00:14.516 -- 00:00:19.305 Before I turn the call over to management, I'd like to remind you that management may 00:00:19.305 -- 00:00:24.434 make forward-looking statements relating to such matters as continued growth prospects 00:00:24.434 -- 00:00:29.530 for the company, uncertainties regarding market acceptance of products, the 00:00:29.530 -- 00:00:34.778 impact of competitive products and pricing, industry trends, and product initiatives, 00:00:34.778 -- 00:00:40.386 including products in the development stage which may not achieve scientific objectives 00:00:40.386 -- 00:00:43.611 or meet stringent regulatory requirements. 00:00:43.611 -- 00:00:48.618 Forward-looking statements are subject to risk and uncertainties that could cause 00:00:48.618 -- 00:00:54.200 actual results to differ materially from those contemplated in such forward-looking statements. 00:00:54.200 -- 00:00:59.267 These statements are based on current available information and management's 00:00:59.267 -- 00:01:04.034 current assumptions, expectations, and projections about future events. 00:01:04.034 -- 00:01:09.241 While management believes its assumptions, expectations, and projections are reasonable 00:01:09.241 -- 00:01:14.389 in the view of currently available information, you are cautioned not to place undue 00:01:14.389 -- 00:01:17.172 reliance on these forward-looking statements. 00:01:17.172 -- 00:01:22.648 The company's actual res...